PRESS RELEASE published on 07/09/2025 at 22:05, 10 months 24 days ago Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance Inventiva appoints Jason Campagna as President of R&D and CMO and Martine Zimmermann as EVP of Regulatory Affairs and Quality Assurance, emphasizing long-term growth and operational excellence Quality Assurance R&D Leadership Appointments Regulatory Affairs Inventiva
BRIEF published on 07/07/2025 at 22:05, 10 months 26 days ago Inventiva Receives $10 Million Milestone Payment from CTTQ Milestone Payment Lanifibranor Biopharmaceutical Development MASH Treatment CTTQ Partnership
PRESS RELEASE published on 07/07/2025 at 22:00, 10 months 26 days ago Inventiva receives $10 million milestone payment from CTTQ Inventiva receives $10 million milestone payment from CTTQ following successful structured financing. Partnership aims to develop lanifibranor for MASH treatment in Chinese regions Inventiva Milestone Payment MASH Lanifibranor CTTQ
BRIEF published on 07/02/2025 at 22:05, 11 months ago Inventiva Publishes Promising Results on Lanifibranor for Liver Disease Phase 2b Study Liver Disease Lanifibranor MASH Treatment Journal Of Hepatology Reports
PRESS RELEASE published on 07/02/2025 at 22:00, 11 months ago Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease Inventiva announces publication in Journal of Hepatology Reports on lanifibranor treatment effects on liver sinusoidal endothelial cells in MASLD/MASH patients and preclinical models, showing potential therapeutic benefits Inventiva MASH Lanifibranor Journal Of Hepatology Reports LSEC Capillarization
BRIEF published on 06/10/2025 at 22:05, 11 months 22 days ago Renée Aguiar-Lucander Joins Inventiva's Board of Directors Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander
PRESS RELEASE published on 06/10/2025 at 22:00, 11 months 22 days ago Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors Inventiva appoints Renée Aguiar-Lucander to its Board of Directors. Aguiar-Lucander brings extensive industry experience and leadership to the company Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander
BRIEF published on 05/27/2025 at 22:05, 1 year ago Inventiva at the Jefferies and UBS Healthcare Conferences Biopharmaceuticals Inventiva MASH UBS Conference Jefferies Conference
PRESS RELEASE published on 05/27/2025 at 22:00, 1 year ago Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference Inventiva to participate in Jefferies Global Healthcare Conference & UBS Spring Biotech Conference. CEO to present at fireside chat in New York City Clinical-stage Biopharmaceutical Company Inventiva Jefferies Global Healthcare Conference Lanifibranor UBS Spring Biotech Conference
BRIEF published on 05/23/2025 at 08:35, 1 year ago Inventiva Reports First Quarter 2025 Financials: Cash Position Declines Financial Results Cash Position Clinical Trial Inventiva Lanifibranor
Published on 06/03/2026 at 14:30, 34 minutes ago BTU Expands Dixie East Project with Strategic Block 3 Acquisition Adjacent to Kinross Great Bear Project
Published on 06/03/2026 at 14:00, 1 hour 4 minutes ago Datametrex Secures New Nutanix Infrastructure Contracts as Enterprise Data Centre Modernization Accelerates
Published on 06/03/2026 at 14:00, 1 hour 4 minutes ago Sky Gold Corp Reports On Gold And Multi-Element Results Indicating Large Polymetallic System With Critical Minerals At Evening Star, Nevada
Published on 06/03/2026 at 13:25, 1 hour 39 minutes ago Metallic Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$10 Million
Published on 06/03/2026 at 13:00, 2 hours 4 minutes ago CoTec Holdings Corp. Joint Venture, HyProMag USA, to Commence Preparatory Work for Project Execution Phase at Dallas-Fort Worth Texas Hub
Published on 06/03/2026 at 14:54, 9 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/03/2026 at 14:50, 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Published on 06/03/2026 at 14:17, 46 minutes ago Press Release_Successful completion of tender offer on Carrefour notes_June 2026
Published on 06/03/2026 at 12:41, 2 hours 23 minutes ago Disclosure of Share Capital and Voting Rights as of Mai 31, 2026
Published on 06/03/2026 at 11:29, 3 hours 35 minutes ago 2026.06.03 Notice to holders of the Convertible Bond ISIN FR0013521085
Published on 06/03/2026 at 08:45, 6 hours 19 minutes ago Air Liquide announces milestone investment in South Korea to support SK hynix’s advanced AI memory chip project
Published on 06/02/2026 at 18:03, 21 hours ago Total number of voting rights and shares making up the share capital at May 31, 2026